- SID Score
- 5.7/10
- Fair value
- $104.76
- Generated
- Oct 2, 2026
- Model
- claude-haiku-4-5-20251001
Oracle Corporation is trading at $141.43 with a substantial valuation disconnect evident between technical support and fair value estimates. The company's SID Score of 5.7/10 reflects mixed fundamental quality, with particularly weak Value (F) and Growth (F) grades offsetting moderate Profitability (C) performance. While analyst consensus remains bullish with an average price target of $319.08, the fair value estimate of $104.76 suggests current valuations may not align with intrinsic worth, creating a potential risk-reward asymmetry for investors.
Oracle's P/E ratio of 36.64 is substantially elevated relative to its fair value discount of -23.6%, indicating significant market premium pricing not justified by current earnings multiples. The Profitability grade of C and extremely weak Value (F) and Growth (F) ratings suggest the company is trading well above fundamentals with limited organic growth justification. With a negligible dividend yield of 0.01%, Oracle offers minimal current income to shareholders, relying instead on capital appreciation for returns. The absence of recent annual financial data in the provided metrics limits deeper analysis of revenue trends, margin expansion, and cash flow generation capabilities.
The RSI(14) of 37.2 indicates oversold conditions, suggesting potential near-term bounce potential or continued downward pressure if support levels fail to hold. Oracle's current price of $141.43 sits between its 50-day moving average of $143.15 and 200-day moving average of $157.57, positioning the stock in a downtrend corridor with resistance overhead. The bearish technical posture combined with declining price trajectory relative to both key moving averages suggests consolidation or further weakness before sustained recovery. The stock's distance from the 200-day MA represents a 10.2% gap that would need to be reclaimed for confirmation of trend reversal.
Analyst & Insider Sentiment
Despite analyst consensus rating of Buy with a $319.08 average price target, insider trading activity presents a conflicting signal with multiple significant sell transactions occurring September 21-22, 2026. Executives Smith Maria and Sicilia Michael D. collectively liquidated approximately 70,000 shares, with Sicilia selling 57,957 shares across two days alone, suggesting insider concern about valuation levels. The recent EPS beat on September 10 (actual $1.92 vs. estimate $1.67, +15%) provides some fundamental support, though subsequent earnings data remain incomplete. This divergence between bullish analyst consensus and bearish insider selling warrants caution regarding price target credibility and timing assumptions.
The primary valuation risk stems from the 23.6% downside to fair value, creating significant correction potential if market sentiment shifts or growth expectations fail to materialize. Insider selling coupled with deteriorating technical indicators (RSI below 40, price below both major moving averages) suggests institutional recognition of overvaluation despite public Buy recommendations. The extremely weak Growth and Value grades combined with neutral news sentiment indicate limited near-term catalysts for sustained appreciation. Additionally, the disconnect between analyst price targets ($319.08) and fair value estimates ($104.76) reflects extreme disagreement on fundamental support levels, amplifying uncertainty around downside protection.
Oracle presents a challenging risk-reward profile for new investors at current levels, with a $36.67 fundamental discount to current price offsetting bullish analyst sentiment. The combination of oversold technical conditions, recent insider liquidation, and weak fundamental grades suggests waiting for improved entry points closer to the $120-130 range may provide better risk management. While the company's Profitability grade of C and historic earnings beats provide some floor support, the deteriorating technical structure and elevated valuation multiples argue for a cautious stance. Conservative investors should wait for RSI confirmation above 50 and price stabilization above the 200-day MA before considering positions, while value investors might monitor for entry near the $104.76 fair value estimate.
